國立虎尾科技大學 |

Behavioral Pharmacology of Neuropeptides: Oxytocin

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Behavioral Pharmacology of Neuropeptides: Oxytocin/ edited by Rene Hurlemann, Valery Grinevich.
other author:	Hurlemann, Rene.
Description:	IX, 593 p. 130 illus., 30 illus. in color.online resource. :
Contained By:	Springer Nature eBook
Subject:	Neurosciences. -
Online resource:	https://doi.org/10.1007/978-3-319-63739-6
ISBN:	9783319637396

Behavioral Pharmacology of Neuropeptides: Oxytocin
Behavioral Pharmacology of Neuropeptides: Oxytocin[electronic resource] /edited by Rene Hurlemann, Valery Grinevich. - 1st ed. 2018. - IX, 593 p. 130 illus., 30 illus. in color.online resource. - Current Topics in Behavioral Neurosciences,351866-3370 ;. - Current Topics in Behavioral Neurosciences,19.

Preface -- Part 1 Human Research -- Oxytocin Administration in Humans. Oxytocin & Human Social Perception. Oxytocin & Human Social Cognition. Oxytocin & Human Pair Bonding. Oxytocin & Human Parenting. Oxytocin & Autism Spectrum Disorders. Oxytocin & Anxiety Disorders. Oxytocin & Borderline Personality Disorder. Oxytocin & Schizophrenia Spectrum Disorders. Oxytocin & Prader-Willi Syndrome. Translating oxytocin research into therapeutics: a precision medicine approach -- Part 2 Animal Research -- Oxytocin Receptor Signaling. Oxytocin & Steroid Action. Oxytocin & Olfaction. Oxytocin & Social Behavior of Primates. Oxytocin & Parental Behavior. Oxytocin & Pain. Oxytocin & Alcohol Abuse. Oxytocin & Autism Spectrum Disorders. Genetics & Early Life Development of the oxytocin system. Oxytocin, Pair-Bonding and Partner Loss. Oxytocin & Cortical Function.

This volume collects cutting-edge expert reviews in the oxytocin field and will be of interest to a broad scientific audience ranging from social neuroscience to clinical psychiatry. The role of the neuropeptide oxytocin in social behaviors is one of the earliest and most significant discoveries in social neuroscience. Influential studies in animal models have delineated many of the neural circuits and genetic components that underlie these behaviors. These discoveries have inspired researchers to investigate the effects of oxytocin on brain and behavior in humans and its potential relevance as a treatment for psychiatric disorders including borderline personality disorder and autism and schizophrenia spectrum disorders. In fact, there is no established social psychopharmacology in Psychiatry, and oxytocin can be seen as the first endogenous agent specifically addressing social-cognitive impairment in psychiatric disorders, with animal research suggesting that it could be especially efficient in the early postnatal period. From a human perspective, it is crucial to understand more precisely who can benefit from potential oxytocin-related treatments, which outcome measures will best represent their effects, how they should be administered, and what brain mechanisms are likely involved in mediating their effects. This type of “precision medicine” approach is in line with the research domain criteria defined by the U.S. National Institute of Mental Health.

ISBN: 9783319637396

Standard No.: 10.1007/978-3-319-63739-6doiSubjects--Topical Terms:

593561
Neurosciences.

LC Class. No.: RC321-580

Dewey Class. No.: 612.8

Behavioral Pharmacology of Neuropeptides: Oxytocin
LDR:03803nam a22004095i 4500 001 990529
003 DE-He213
005 20200629222844.0
007 cr nn 008mamaa
008 201225s2018 gw | s |||| 0|eng d
020 $a 9783319637396 $9 978-3-319-63739-6
024 7 $a 10.1007/978-3-319-63739-6 $2 doi
035 $a 978-3-319-63739-6
050 4 $a RC321-580
072 7 $a PSAN $2 bicssc
072 7 $a MED057000 $2 bisacsh
072 7 $a PSAN $2 thema
082 0 4 $a 612.8 $2 23
245 1 0 $a Behavioral Pharmacology of Neuropeptides: Oxytocin $h [electronic resource] / $c edited by Rene Hurlemann, Valery Grinevich.
250 $a 1st ed. 2018.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2018.
300 $a IX, 593 p. 130 illus., 30 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
490 1 $a Current Topics in Behavioral Neurosciences, $x 1866-3370 ; $v 35
505 0 $a Preface -- Part 1 Human Research -- Oxytocin Administration in Humans. Oxytocin & Human Social Perception. Oxytocin & Human Social Cognition. Oxytocin & Human Pair Bonding. Oxytocin & Human Parenting. Oxytocin & Autism Spectrum Disorders. Oxytocin & Anxiety Disorders. Oxytocin & Borderline Personality Disorder. Oxytocin & Schizophrenia Spectrum Disorders. Oxytocin & Prader-Willi Syndrome. Translating oxytocin research into therapeutics: a precision medicine approach -- Part 2 Animal Research -- Oxytocin Receptor Signaling. Oxytocin & Steroid Action. Oxytocin & Olfaction. Oxytocin & Social Behavior of Primates. Oxytocin & Parental Behavior. Oxytocin & Pain. Oxytocin & Alcohol Abuse. Oxytocin & Autism Spectrum Disorders. Genetics & Early Life Development of the oxytocin system. Oxytocin, Pair-Bonding and Partner Loss. Oxytocin & Cortical Function.
520 $a This volume collects cutting-edge expert reviews in the oxytocin field and will be of interest to a broad scientific audience ranging from social neuroscience to clinical psychiatry. The role of the neuropeptide oxytocin in social behaviors is one of the earliest and most significant discoveries in social neuroscience. Influential studies in animal models have delineated many of the neural circuits and genetic components that underlie these behaviors. These discoveries have inspired researchers to investigate the effects of oxytocin on brain and behavior in humans and its potential relevance as a treatment for psychiatric disorders including borderline personality disorder and autism and schizophrenia spectrum disorders. In fact, there is no established social psychopharmacology in Psychiatry, and oxytocin can be seen as the first endogenous agent specifically addressing social-cognitive impairment in psychiatric disorders, with animal research suggesting that it could be especially efficient in the early postnatal period. From a human perspective, it is crucial to understand more precisely who can benefit from potential oxytocin-related treatments, which outcome measures will best represent their effects, how they should be administered, and what brain mechanisms are likely involved in mediating their effects. This type of “precision medicine” approach is in line with the research domain criteria defined by the U.S. National Institute of Mental Health.
650 0 $a Neurosciences. $3 593561
650 0 $a Psychiatry. $3 585488
650 0 $a Behavioral sciences. $3 1148596
650 0 $a Endocrinology . $3 1254221
650 2 4 $a Behavioral Sciences. $3 1065492
650 2 4 $a Endocrinology. $3 645497
700 1 $a Hurlemann, Rene. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1206874
700 1 $a Grinevich, Valery. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1206875
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783319637389
776 0 8 $i Printed edition: $z 9783319637402
776 0 8 $i Printed edition: $z 9783030097035
830 0 $a Current Topics in Behavioral Neurosciences, $x 1866-3370 ; $v 19 $3 1253607
856 4 0 $u https://doi.org/10.1007/978-3-319-63739-6
912 $a ZDB-2-SBL
912 $a ZDB-2-SXB
950 $a Biomedical and Life Sciences (SpringerNature-11642)
950 $a Biomedical and Life Sciences (R0) (SpringerNature-43708)